General AML,   IDH1/2

Agnieszka Wierzbowska | EHA 2018|  Current and emerging treatment options for elderly AML patients?

L: English
Watch Polish version

At the 23rd Congress of the European Hematology Association,  Agnieszka Wierzbowska comments on the emerging treatment for elderly acute myeloid leukemia (AML). Agnieszka discussed a range of studies using venetoclax in the unfit population of elderly AML patients. She concluded that the new combinations of the standard treatment provide a new hope for elderly AML patients. 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF